Status:
COMPLETED
Pulmicort Respules 0.25/0.5 Specific Clinical Experience Investigation
Lead Sponsor:
AstraZeneca
Conditions:
Bronchial Asthma
Eligibility:
All Genders
6-5 years
Brief Summary
The purpose of this study is to investigate the safety and efficacy for long term treatment of the drug in children aged 6 months and \< 5 years on bronchial asthma in daily clinical usage.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients treated with Pulmicort Respules for the first time due to bronchial asthma
- Children of \>= 6 months and \< 5 years old age at the start of study treatment
Exclusion
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
633 Patients enrolled
Trial Details
Trial ID
NCT01232322
Start Date
October 1 2006
End Date
July 1 2011
Last Update
January 24 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.